First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.43 USD -1.38% Market Closed
Updated: May 16, 2024

Interpace Biosciences Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Interpace Biosciences Inc
Gross Profit Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Gross Profit
$23.9m
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
0%
DaVita Inc
NYSE:DVA
Gross Profit
$4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
1%
Quest Diagnostics Inc
NYSE:DGX
Gross Profit
$3.1B
CAGR 3-Years
-10%
CAGR 5-Years
3%
CAGR 10-Years
1%
CVS Health Corp
NYSE:CVS
Gross Profit
$53.6B
CAGR 3-Years
-20%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Cigna Corp
NYSE:CI
Gross Profit
$25.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Gross Profit
$3.4B
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
5%

See Also

What is Interpace Biosciences Inc's Gross Profit?
Gross Profit
23.9m USD

Based on the financial report for Dec 31, 2023, Interpace Biosciences Inc's Gross Profit amounts to 23.9m USD.

What is Interpace Biosciences Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
0%

Over the last year, the Gross Profit growth was 31%. The average annual Gross Profit growth rates for Interpace Biosciences Inc have been 31% over the past three years , 15% over the past five years .